References to Primary Literature
- Francis, New England J Med. 1985 7 313.
- Selkoe DJ Scientific American 199168–78.
- Sabb AL, Haskins Current Opin in Thera Patents 1991 1 8 1124–1132.
- Johnson G, Thomas A Current Opin in Thera Patents 1991 1 8 1133–1138.
- Sunderland T, Molchan S, Vitiello B, Martinez R, Martin A Cholinergic Basis for Alzheimer Therapy Becker R. Giacobini E. BirkhauserBoston 1991172–182.
- Karczmar AG Cholinergic Basis for Alzheimer Therapy Becker R. Giacobini E. BirkhauserBoston 1991141–152.
- Giacobini E Cholinergic Basis for Alzheimer Therapy Becker R. Giacobini E. BirkhauserBoston 1991247–262.
- Becker RE, Moriearty P, Unni L Cholinergic Basis for Alzheimer Therapy Becker R. Giacobini E. BirkhauserBoston 1991263–296.
- Giacobini E, Linville D, Messamore E, Ogane N Cholinergic Basis for Alzheimer Therapy Becker R. Giacobini E. BirkhauserBoston 1991477–490.
- Cuello AC, Garofalo L, Maysinger, Ribeiroda-Silvia A Cholinergic Basis for Alzheimer Therapy Becker R. Giacobini E. BirkhauserBoston 1991445–452.
- Angelucci L, Alema SG, Imperato A, Castorina M, Ramacci MT, Scroocco MG Cholinergic Basis for Alzheimer Therapy Becker R. Giacobini E. BirkhauserBoston 1991134–140.
- Pepeu G, Pepeu IM, Casamenti F Drug Design and Delivery 1990 7 1–1990.
- Lindvall O TINS 1991 14 8 376–384.
- Dunnett S TINS 1991 14 8 371–376.
- DeNoble VJ, DeNoble KF, Spencer KR, Johnson LC, Cook L, Myers MJ, Scribner RM Pharmacol. Biochem. Behavior 1990 36 957–1990.
- Cook L, Nickolson VJ, Steinfels GF, Rohrbach KW, DeNoble VJ Drug Dev. Res. 1990 19 301–1990.
- Nickolson VJ, Tam SW, Myers MJ, Cook L Drug Dev. Res. 1990 19 285–1990.
- Sussman JL, Silman I, Harel M, Frolow F, Oefner C, Goldman A, Toker L Science 1991 253 872–1991.
- Lehmann J Drugs Future 1989 14 11 1059–1071.
- Scrip 1991 1609 25.
- Paterson IA, Juorio AV, Berry MD, Zhu MY J. Pharmacol. Exp. Ther. 1991 258 3 1019–1026.
- Tam SW, Rominger D, Nickolson Mol. Pharmacol. 1991 40 16–1991.
References to Patent Literature
- DuPont Co, US4760083 1988.
- DuPont Merck Pharm Co, WO9113359.
- American Cyanamid Co, EP-447836-A.
- US Dept of Commerce, WO9114004.
- Oxford Virology, WO911577A.
- ER Squibb & Sons Inc, EP-459454-A.
- Molecular RX Inc, WO9116819.
- Hoechst-Roussel, EP-440145-A.
- Hoechst-Roussel, EP-457318-A.
- Pfizer, EP-441517-A.
- Pharmetrix Corp, WO9112758.
- Israel Inst for Biological Research, EP-452101-A.
- Roussel-Uclaf, EP-452170-A.
- Hoechst-Roussel, EP-456196-A.
- Boehringer Ingelheim KG, EP-458214-A.
- Merrell Dow Pharm. Inc, EP-452926-A.
- Israel Inst for Biological Research, US5053412.
- Fisons, WO9111995.
- Pfizer, WO9112005.
- Warner-Lambert, EP-446570-A.
- University of Oregon, WO9112797.
- Shionogi Seiyaku KK, EP-456183-A.
- Synergen Inc, EP-450386-A.
- Ebewe Arzneimittel GmbH EP-452299-A.
- Fidia Spa, EP-457671-A.
- ER Squibb & Sons Inc, US5037821.
- Merck & Co Inc, WO9111909.
- Sankyo Co, EP-456519-A.
- Sigma-Tau Ind, EP-442850-A.
- Sigma-Tau Ind, EP-443996-A.
- Natural Products Sciences Inc, EP-436332-A.
- Pfizer, US5037846.
- Teva Pharm Ind Ltd, EP-436492-A.
- DuPont Co, WO9110433.
- Efamol Holdings plc, EP-440341-A.
- Hoffmann-La Roche Inc, US5015653.
- Hoechst-Roussel, US5053511.
- Hoechst-Roussel, US4970218.
- Hoechst-Roussel, EP-415103-A.
- Hoechst-Roussel, EP-415103-A.
- Hoechst-Roussel, US4983608.
- Rockefeller University, EP-457295-A.
- Farmos-Yhtyma Oy, GB2244431-A.
- Tsuji, EP-458673-A.